LAUSR

This study aimed to examine the role of estrogen receptor (ER)‐α36 in the metastasis of hepatocellular carcinoma (HCC) and in the epithelial‐mesenchymal transition (EMT). HCC HepG2 and Huh7 cells with the knocked‐down level of ER‐α36 expression were established. Cell growth and migration of the HepG2 and Huh7 cell variants were studied using MTS, transwell, and wound‐healing assays, and the metastatic abilities of HepG2 cell variants were examined using a tail‐vein injection model in nude mice. Levels of EMT markers, Src phosphorylation in HepG2 and Huh7 cell variants, and tumors formed by HepG2 cell variants in the nude mice were examined using Western blot and immunohistochemistry. We found that the growth and metastatic abilities of HepG2 and Huh7 cells with the knocked‐down level of ER‐α36 expression (HepG2/Si36 and Huh7/Si36) were significantly reduced, with increased levels of cytokeratin and E‐Cadherin expression, and decreased levels of Vimentin, Snail, Slug and the Src phosphorylation, compared to the HCC cells transfected with an empty vector (HepG2/Vector and Huh7/Vector). We also found ER‐α36 knockdown suppressed the lung metastasis of HepG2 cells with the involvement of EMT and the Src pathway in vivo. The Src inhibitor PP2 suppressed the growth and migration of HepG2/Vector and Huh7/Vector cells with decreased Vimentin, Snail, and Slug and increased cytokeratin and E‐Cadherin expressions, but failed to induce the migration and the EMT markers in HepG2/Si36 and Huh7/Si36 cells. ER‐α36 is involved in the metastasis of HCC cells through the regulation of EMT and the Src signaling pathway.